A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycin.
JAMA., Apr;253(14):2061-7 (1985)
Randomized clinical trial of tamoxifen alone or combined with fluoxymesterone in postmenopausal women with metastatic breast cancer.
J. Clin. Oncol., May;6(5):825-31 (1988)
Randomized clinical trial of CFP versus CMFP in women with metastatic breast cancer.
Cancer., May;63(10):1931-7 (1989)
Randomized trial of doxorubicin alone or combined with vincristine and mitomycin C in women with metastatic breast cancer.
Am. J. Clin. Oncol., Dec;12(6):474-80 (1989)
Treatment of limited-stage small-cell lung cancer with cyclophosphamide, doxorubicin, and vincristine with or without etoposide: a randomized trial of the North Central Cancer Treatment Group.
J. Clin. Oncol., Jan;8(1):33-8 (1990)
Systemic adjuvant therapy in women with resected node-negative breast cancer.
Mayo Clin. Proc., Aug;66(8):805-13 (1991)
A phase III trial of mitomycin C alone versus mitomycin C, vinblastine, and cisplatin for metastatic squamous cell lung carcinoma.
Cancer., Nov;70(9):2281-7 (1992)
Prospective phase I evaluation of radiation therapy, 5-fluorouracil, and levamisole in locally advanced gastrointestinal cancer.
Int. J. Radiat. Oncol. Biol. Phys., Jan;28(2):439-43 (1994)
Phase II trial of topotecan for the treatment of mesothelioma.
Am. J. Clin. Oncol., Dec;21(6):610-3 (1998)
Phase II study of high-dose somatostatin analogue in patients either previously treated or untreated who have extensive-stage small cell lung cancer.
Am. J. Clin. Oncol., Feb;22(1):15-7 (1999)